2006
DOI: 10.1016/j.cca.2005.07.017
|View full text |Cite
|
Sign up to set email alerts
|

Toll-like receptor (TLR)-9 promotor polymorphisms and atherosclerosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
44
0
2

Year Published

2007
2007
2022
2022

Publication Types

Select...
4
4
1

Relationship

0
9

Authors

Journals

citations
Cited by 65 publications
(47 citation statements)
references
References 20 publications
1
44
0
2
Order By: Relevance
“…26 , 38 , 48 , 49 These exaggerated responses may involve several mechanisms, including changes in ligand binding sites on the receptor, thereby affecting ligand affinity and strength of stimulation, changes in transcription factor binding sites on the TLR promoter, 50 or qualitative/ quantitative changes in the TLR protein. In regard to TLR9 SNP genotypes, the C allele at −1237, in the promoter region, has been shown to affect promoter activity, 51 most likely by modifying a potential binding site for the transcription factor NF-κB.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…26 , 38 , 48 , 49 These exaggerated responses may involve several mechanisms, including changes in ligand binding sites on the receptor, thereby affecting ligand affinity and strength of stimulation, changes in transcription factor binding sites on the TLR promoter, 50 or qualitative/ quantitative changes in the TLR protein. In regard to TLR9 SNP genotypes, the C allele at −1237, in the promoter region, has been shown to affect promoter activity, 51 most likely by modifying a potential binding site for the transcription factor NF-κB.…”
Section: Discussionmentioning
confidence: 99%
“…In regard to TLR9 SNP genotypes, the C allele at −1237, in the promoter region, has been shown to affect promoter activity, 51 most likely by modifying a potential binding site for the transcription factor NF-κB. 50 NF-κB is a complex of proteins that remains in cells in an inactive state and is rapidly activated by a series of cascade events after ligands are bound to TLRs. Qualitative or quantitative changes in NF-κB activation may in turn lead to altered transcription regulation of inflammatory cytokine genes, which could lead to alterations in the production of cytokines such as IFN-γ.…”
Section: Discussionmentioning
confidence: 99%
“…Deletions spanning the À3.2 to À0.7 kb promoter region did not alter the TLR9 promoter activity, 30 although the region was shown to be important for the Human Papillomavirus 16-mediated inhibition of TLR9 expression. 31 In silico analysis of the TLR9 promoter showed that the À1237T4C change introduces a putative c-Rel/NF-kB transcription factor binding site; 32 in vitro gene reporter assays showed that the TLR9 À1237T4C SNP alters the TLR9 promoter activity, with the À1237T allele having a higher promoter activity (P¼0.018), suggesting the existence of regulatory elements across the polymorphic site 33 and implying that the À1237C allele is associated with lower TLR9 expression levels.…”
Section: Discussionmentioning
confidence: 99%
“…1). This extra binding site was postulated to enhance the transcriptional activation of TLR9 and potentially affect CpG-DNA-induced activation of proinflammatory chemokines, cytokines, and the adaptive immune response (13). However, a recent report ex-amining the association of rs5743836 with atopic eczema showed that the risk allele was the "T" allele.…”
mentioning
confidence: 99%